Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2016

View Archived Issues

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Mitsubishi Tanabe begins phase II trial of MT-3995 in NASH

Obeticholic acid granted positive CHMP opinion as treatment of primary biliary cholangitis

PhoreMost and University of Cambridge collaborate to identify novel targets

Japan Tobacco and JW Pharmaceutical enter license agreement for JTZ-951 in Republic of Korea

Clinical trial update for the INEXAS phase IIa study evaluating AZD-9412 in patients with asthma

Sunesis Pharmaceuticals submits response to EMA regarding vosaroxin MAA

Early first-in-human results indicate PTC-596 can achieve active plasma levels in cancer patients

EMA committee recommends approval of Rekovelle

Inhibition of APOBEC3B activity improves clinical benefit of tamoxifen in breast cancer

Allegro Ophthalmics' DEL MAR study meets primary and secondary endpoints

Clementia Pharmaceuticals reports positive results from phase II study of palovarotene

NEDD4L plays a critical role in the regulation of cortex development

Hua reports promising phase II results of glucokinase activator HMS-5552

TSHZ3 identified as a new gene linked to autism spectrum disorders

Myocardial PET imaging with CardioPET shows promise in phase II study

Bristol-Myers Squibb receives positive CHMP opinion for nivolumab

Leopold-Franzens Universitaet Innsbruck patents KOR agonists

Zhejiang Hisun Pharmaceutical discloses romidepsin analogues

Cancer Research Technology describes HSF1 inhibitors

Merck KGaA develops ATM kinase inhibitors

Cynata reports promising preclinical findings for MSC technology in mouse model of asthma

Toray Industries presents analgesic agents

Novel BICD2 mutations may cause SMALED2

AbbVie receives positive opinion for Venclyxto tablets in patients with difficult-to-treat CLL

FDA grants orphan drug designation to Genentech's atezolizumab in SCLC

DNAJB6 mutation is associated with myofibrillar myopathies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...